Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtre
Ajouter des filtres








Gamme d'année
1.
Article Dans Anglais | IMSEAR | ID: sea-38653

Résumé

Lansoprazole 30 mg, amoxicillin 1000 mg, and tinidazole 500 mg were given twice daily to 39 peptic ulcer patients (26 duodenal and 13 gastric ulcer, mean age 52.4 +/- 15.01) who had H. pylori infection for two weeks. Additional lansoprazole 30 mg daily was given to duodenal and gastric ulcer patients for another two and six weeks respectively. Follow-up gastroduodenoscope was performed at fourth and eighth week and eighth and twelfth week for all duodenal and gastric ulcer patients, respectively. H. pylori status was evaluated by rapid urease test (CLO test) and histology at first and last endoscope. The ulcers were healed at the last endoscopy in 11 (85%) gastric ulcer patients and 24 (92%) duodenal ulcers patients. H. pylori infection was eradicated in 31 patients (79%). Mild side effects were observed in 15 per cent. In conclusion, 2 week regimen of lansoprazole, amoxicillin, and tinidazole triple therapy resulted in a relatively high healing rate of peptic ulcer (90%) and an acceptable eradication rate of H. pylori infection (79%).


Sujets)
(Pyridin-2-ylméthyl)sulfinyl-1H-benzimidazoles , Adulte , Sujet âgé , Sujet âgé de 80 ans ou plus , Amoxicilline/administration et posologie , Antitrichomonas/administration et posologie , Association de médicaments , Antienzymes/administration et posologie , Femelle , Études de suivi , Infections à Helicobacter/traitement médicamenteux , Helicobacter pylori/effets des médicaments et des substances chimiques , Humains , Mâle , Adulte d'âge moyen , Oméprazole/administration et posologie , Pénicillines/administration et posologie , Ulcère peptique/traitement médicamenteux , Thaïlande , Tinidazole/administration et posologie , Résultat thérapeutique
SÉLECTION CITATIONS
Détails de la recherche